Stay updated on MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial
Sign up to get notified when there's something new on the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page.
Latest updates to the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check16 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in study record information.SummaryDifference1%
- Check23 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference1%
- Check31 days agoNo Change Detected
- Check38 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check45 days agoChange DetectedThe website has added new content, while the FDA Safety Alerts and Recalls section has been removed.SummaryDifference0.2%
- Check52 days agoChange DetectedThe protocol for the Phase 1b Sub-Study of MRTX1719 has been updated with new inclusion and exclusion criteria, while previous criteria have been removed, indicating a refinement in the study's focus on solid tumor malignancies with MTAP homozygous deletion.SummaryDifference6%
Stay in the know with updates to MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page.